New study aims to find cancer cures in survivors’ immune cells
Etcembly has launched a new research study aiming to uncover new targets for cancer therapies by analysing the immune cells of cancer survivors. The ETCh study is recruiting people aged 18-65 who are living with or have survived cancer to join the study, as well as… Read More
